Related Reading: For dosing conventions, see BPC-157 Dosing Protocols
Fournel-Gigleux S, Sutherland L, Sabolovic N, Burchell B, Siest G
This enhanced delivery is largely attributed to the high expression of the OCTN1 transporter in ocular tissues, particularly in the retina, enabling active, targeted transport and overcoming the delivery efficiency limitations of conventional eye drops
Fix: Only bill a separate E/M service when the documentation supports distinct medical decision-making beyond "patient here for injection." Dose adjustments, side effect management, and review of treatment progress all support a separate E/M service, but they must be documented
For Manufacturers and Formulators For manufacturers and formulators, Setria provides a clinically evaluated source of glutathione produced under established quality standards